Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 339

Similar articles for PubMed (Select 18342452)

1.

Apocrine carcinomas of the breast in Turkish women: hormone receptors, c-erbB-2 and p53 immunoexpression.

Kaya H, Bozkurt SU, Erbarut I, Djamgoz MB.

Pathol Res Pract. 2008;204(6):367-71. doi: 10.1016/j.prp.2008.01.012. Epub 2008 Mar 14.

PMID:
18342452
3.

Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.

Honma N, Takubo K, Akiyama F, Sawabe M, Arai T, Younes M, Kasumi F, Sakamoto G.

Histopathology. 2005 Aug;47(2):195-201.

PMID:
16045781
4.

Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.

Nakopoulou LL, Alexiadou A, Theodoropoulos GE, Lazaris AC, Tzonou A, Keramopoulos A.

J Pathol. 1996 May;179(1):31-8.

PMID:
8691341
5.

Schirrous invasive ductal carcinoma of the breast overexpress p53 oncoprotein.

Ferrini FS, Rossi MA, Neto MM, Soares FA.

Sao Paulo Med J. 2001 Jan 4;119(1):4-6.

6.
7.
8.

The significance of c-erbB-2 overexpression and p53 expression in patients with axillary lymph node--negative breast cancer: a tissue microarray study.

Ko SS, Na YS, Yoon CS, Park JY, Kim HS, Hur MH, Lee HK, Chun YK, Kang SS, Park BW, Lee JH.

Int J Surg Pathol. 2007 Apr;15(2):98-109.

PMID:
17478762
9.
11.
12.
13.

Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast.

Honma N, Takubo K, Arai T, Younes M, Kasumi F, Akiyama F, Sakamoto G.

APMIS. 2006 Oct;114(10):712-9.

PMID:
17004974
16.

p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast.

Rudas M, Neumayer R, Gnant MF, Mittelböck M, Jakesz R, Reiner A.

Eur J Cancer. 1997 Jan;33(1):39-44.

PMID:
9071897
17.

C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.

Logullo AF, Lopes AB, Nonogaki S, Soares FA, Netto MM, Nishimoto IN, Brentani MM.

Oncol Rep. 2007 Jul;18(1):121-6.

PMID:
17549356
18.
19.

Immunoexpression of HER family, neuregulin, MAPK and AKT in invasive ductal carcinomas of the breast.

Kaya H, Erbarut I, Ozkan N, Bekiroğlu N, Sen S, Abaciğlu U.

Eur J Gynaecol Oncol. 2008;29(4):350-6.

PMID:
18714568
20.

Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.

Hussein MR, Abd-Elwahed SR, Abdulwahed AR.

Cell Biol Int. 2008 Jun;32(6):698-707. doi: 10.1016/j.cellbi.2008.01.007. Epub 2008 Jan 25.

PMID:
18296077
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk